PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28849081-6	2017	The results of the present study demonstrated that lercanidipine and FK506 inhibited Ang II-induced cardiomyocyte hypertrophy, as evidenced by decreases in fetal gene (atrial natriuretic peptide and brain natriuretic peptide) expression levels and cell surface area.	Tacrolimus	69-74	angiotensinogen	Rattus norvegicus	85-91	
22184128-3	2012	We investigated effects of two calcineurin inhibitors, cyclosporine A (CsA) and tacrolimus (FK506) (10-10-10-6 mol/L, 20 mins) on activation of MAP kinases and on growth, pro-fibrotic and pro-inflammatory responses in Ang II-stimulated rat cardiac fibroblasts.	Tacrolimus	80-90	angiotensinogen	Rattus norvegicus	218-224	
22184128-5	2012	FK506, but not CsA, attenuated Ang II-stimulated MAP kinase activation.	Tacrolimus	0-5	angiotensinogen	Rattus norvegicus	31-37	
16838106-6	2007	Ang II-induced apoptosis was inhibited by CV-11974 (Candesartan; Ang II type 1 [AT1] receptor blocker), SK&F96365, and FK506 (calcineurin inhibitor).	Tacrolimus	123-128	angiotensinogen	Rattus norvegicus	0-6	
25752645-9	2015	Importantly, we showed that calcineurin-dependent NFAT3 nuclear translocation was essential to AngII-mediated IL-6 transcription, QL mimicked the effect of FK506, the calcineurin inhibitor, on suppression of IL-6 expression and stress fibres formation.	Tacrolimus	156-161	angiotensinogen	Rattus norvegicus	95-100	
23657856-0	2013	Scavengers of reactive oxygen species, paracalcitol, RhoA, and Rac-1 inhibitors and tacrolimus inhibit angiotensin II-induced actions on glomerular permeability.	Tacrolimus	84-94	angiotensinogen	Rattus norvegicus	103-117